Prevention Status Reports: Center for Disease Control and Prevention. 2017. https://www.cdc.gov/psr/index.html.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief. 2017:1–8.
Palatnik A, Grobman WA. Induction of labor versus expectant management for women with a prior cesarean delivery. Am J Obstet Gynecol. 2015;212:358.e1–6.
Prescription painkiller overdoses: a growing epidemic, especially among women. Center for Disease Control and Prevention; 2018. https://www.cdc.gov/vitalsigns/prescriptionpainkilleroverdoses/index.html.
Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol. 2016;215:353.e1–18.
Peahl AF, Dalton VK, Montgomery JR, Lai YL, Hu HM, Waljee JF. Rates of new persistent opioid use after vaginal or cesarean birth among US women. JAMA Netw Open. 2019;2:e197863.
Article PubMed PubMed Central Google Scholar
Bjornnes AK, Rustoen T, Lie I, Watt-Watson J, Leegaard M. Pain characteristics and analgesic intake before and following cardiac surgery. Eur J Cardiovasc Nurs. 2016;15:47–54.
Singh JA, Lewallen D. Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5707 THAs at 2-years and 3289 THAs at 5-years. BMC Musculoskelet Disord. 2010;11:90.
Article PubMed PubMed Central Google Scholar
Fecho K, Miller NR, Merritt SA, Klauber-Demore N, Hultman CS, Blau WS. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009;10:708–15.
Holland E, Bateman BT, Cole N, Taggart A, Robinson LA, Sugrue R, et al. Evaluation of a quality improvement intervention that eliminated routine use of opioids after cesarean delivery. Obstet Gynecol. 2019;133:91–7.
Prabhu M, Dubois H, James K, Leffert LR, Riley LE, Bateman BT, et al. Implementation of a quality improvement initiative to decrease opioid prescribing after cesarean delivery. Obstet Gynecol. 2018;132:631–6.
Article PubMed PubMed Central Google Scholar
Prabhu M, McQuaid-Hanson E, Hopp S, Burns SM, Leffert LR, Landau R, et al. A shared decision-making intervention to guide opioid prescribing after cesarean delivery. Obstet Gynecol. 2017;130:42–6.
Article PubMed PubMed Central Google Scholar
Smith AM, Young P, Blosser CC, Poole AT. Multimodal stepwise approach to reducing in-hospital opioid use after cesarean delivery: a quality improvement initiative. Obstet Gynecol. 2019;133:700–6.
Schug SA, Raymann A. Postoperative pain management of the obese patient. Best Pract Res Clin Anaesthesiol. 2011;25:73–81.
Article CAS PubMed Google Scholar
R Core Team. R: a lagnuage and environment for statistical computing. R Foundation for Statistical Computing; 2020.
Mullman L, Hilden P, Goral J, Gwacham N, Tauro C, Spinola K, et al. Improved outcomes with an enhanced recovery approach to cesarean delivery. Obstet Gynecol. 2020;136:685–91.
Article CAS PubMed PubMed Central Google Scholar
Prabhu M, Dolisca S, Wood R, James K, Bateman BT, Barth WH Jr, et al. Postoperative opioid consumption after scheduled compared with unscheduled cesarean delivery. Obstet Gynecol. 2019;133:354–63.
Article CAS PubMed Google Scholar
Walker Z, Perkins C, Harper L, Jauk V, Szychowski JM, Mazzoni S. The effects of antepartum depressive symptoms on postcesarean opioid consumption. Am J Perinatol. 2022;39:106–12.
Badreldin N, Grobman WA, Yee LM. Inpatient opioid use after vaginal delivery. Am J Obstet Gynecol. 2018;219:608.e1–7.
Wong M, Vogell A, Wright K, Keith I, Loring M, Morria S. Opioid use after lapaorscopic hysterectomy: prescriptions, patient use, and a predictive calculator. Am J Obstet Gynecol. 2019;220:259.e1–11.
Wright J, Huang Y, Melamed A, Tergas A, St. Clair C, Hou J, et al. Use and misuse of opioids after gynecologic surgical procedures. Obstet Gynecol. 2019;134:250–60.
Article CAS PubMed Google Scholar
Lloret-Linares C, Lopes A, Decleves X, Serrie A, Mouly S, Bergmann JF, et al. Challenges in the optimisation of post-operative pain management with opioids in obese patients: a literature review. Obes Surg. 2013;23:1458–75.
Article CAS PubMed Google Scholar
lloret-Linares CD, Decleves X, Oppert JM, Basdevant A, Clement K, Bardin C, et al. Pharmacology of morphine in obese patient. Clin Pharmacokinet. 2009;48:635–51.
Miscio G, Guastamacchia G, Brunani A, Priano L, Baudo S, Mauro A. Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv System. 2005;10:354–8.
Lloret Linares C, Hajj A, Poitou C, Simoneau G, Clement K, Laplanche JL, et al. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population. Obes Surg. 2011;21:1257–64.
Kutlu S, Canpolat S, Sandal S, Ozcan M, Sarsilmaz M, Kelestimur H. Effects of central and peripheral administration of leptin on pain threshold in rats and mice. Neuroendocrinol Lett. 2003;24:193–6.
Comments (0)